Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 313

1.

Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study.

Yarnell JW, Sweetnam PM, Rumley A, Lowe GD.

Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):271-9.

2.

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC.

Circulation. 1991 Mar;83(3):836-44.

PMID:
1999035
3.

Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.

Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3321-5.

5.

Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.

Lip GY, Blann AD, Jones AF, Lip PL, Beevers DG.

Am J Cardiol. 1997 Dec 15;80(12):1566-71.

PMID:
9416937
6.

Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.

Mukamal KJ, Jadhav PP, D'Agostino RB, Massaro JM, Mittleman MA, Lipinska I, Sutherland PA, Matheney T, Levy D, Wilson PW, Ellison RC, Silbershatz H, Muller JE, Tofler GH.

Circulation. 2001 Sep 18;104(12):1367-73.

7.

Lifestyle factors and coagulation activation markers: the Caerphilly Study.

Yarnell JW, Sweetnam PM, Rumley A, Lowe GD.

Blood Coagul Fibrinolysis. 2001 Dec;12(8):721-8.

PMID:
11734674
8.

C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):603-10.

9.

Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.

Smith FB, Rumley A, Lee AJ, Leng GC, Fowkes FG, Lowe GD.

Br J Haematol. 1998 Mar;100(4):758-63.

PMID:
9531345
10.

Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.

Suadicani P, Hein HO, von Eyben FE, Gyntelberg F.

Metab Syndr Relat Disord. 2009 Apr;7(2):97-104. doi: 10.1089/met.2008.0041.

PMID:
19032035
11.

A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease.

Woodward M, Rumley A, Welsh P, MacMahon S, Lowe G.

J Thromb Haemost. 2007 Sep;5(9):1795-800.

12.

Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.

Yarnell J, McCrum E, Rumley A, Patterson C, Salomaa V, Lowe G, Evans A.

Eur Heart J. 2005 Feb;26(4):332-42; discussion 317-8. Epub 2004 Nov 30.

PMID:
15618045
14.
15.

Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies.

Yarnell JW, Patterson CC, Sweetnam PM, Lowe GD.

Eur Heart J. 2004 Jun;25(12):1049-56.

PMID:
15191776
16.

Socioeconomic status and determinants of hemostatic function in healthy women.

Wamala SP, Murray MA, Horsten M, Eriksson M, Schenck-Gustafsson K, Hamsten A, Silveira A, Orth-Gomér K.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):485-92.

17.

Maternal and cord blood hemostasis at delivery.

Schneider DM, von Tempelhoff GF, Herrle B, Heilmann L.

J Perinat Med. 1997;25(1):55-61.

PMID:
9085204
18.

Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.

Mannucci PM, Bernardinelli L, Foco L, Galli M, Ribichini F, Tubaro M, Peyvandi F.

J Thromb Haemost. 2005 Feb;3(2):280-6.

19.

Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study.

Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL.

Circulation. 1998 Apr 21;97(15):1467-73.

20.

Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK.

Circulation. 1999 Aug 17;100(7):736-42.

Supplemental Content

Support Center